Recent research reveals overlapping symptoms between avoidant/restrictive food intake disorder (ARFID) and other restrictive eating disorders, challenging traditional diagnostic distinctions and calling for a more flexible clinical approach.
Eating-disorder researchers are increasingly finding that avoidant/restrictive food intake disorder, or ARFID, is not always as neatly separate from other restrictive eating disorders as diagnostic manuals suggest. A study published in Psychological Medicine used latent profile analysis in 202 treatment-seeking people aged 10 to 79 and identified five patterns of symptoms, including one group that combined ARFID-style avoidance with restraint driven by body shape or weight concerns. That mixed profile was relatively small, at 8% of the sample, but it challenges the idea that ARFID and weight-related restriction always sit on opposite sides of a clear diagnostic line.
Further evidence points in the same direction. Research in adults with probable ARFID found that shape and weight concerns can be present at levels similar to those seen in the general population, even when they are not the main reason for restriction. The same work suggested that higher body weight was linked with greater shape and weight concerns, reinforcing the idea that ARFID can appear across the weight spectrum rather than only in underweight patients. Similar findings have also emerged from Swedish adult data using the Nine Item ARFID Screen, which again showed that body-image concerns may coexist with ARFID symptoms.
The overlap is not entirely new. Earlier studies of eating disorders have long shown that symptoms can shift over time, with diagnostic crossover between anorexia nervosa, bulimia nervosa and other patterns of disordered eating. Reviews and longitudinal studies have also argued that rigid diagnostic boundaries can miss the way restrictive eating evolves in real life. More recent work on ARFID in children and adolescents has found that multiple restriction motives often cluster together, yet treatment outcomes may be similar across profiles, suggesting that clinical presentation can be heterogeneous even when the label remains the same.
Taken together, the findings add weight to calls for a more flexible understanding of eating disorders. They also raise practical questions for clinicians assessing whether restriction stems from sensory sensitivity, low appetite, fear of choking or vomiting, or from a desire to control shape and weight. The newer studies do not prove that ARFID and anorexia nervosa are the same condition, but they do suggest that the boundary between them can blur, and that clinicians may need to look beyond a single primary motive when diagnosing and treating patients.
Disclaimer: This content is for informational purposes only and is not intended to be a substitute for professional medical judgment, advice, diagnosis, or treatment.
